Achieve Life Sciences (ACHV) Short Interest Ratio & Short Volume

Short interest is the volume of Achieve Life Sciences shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 717,500 shares of ACHV short. Learn More on Achieve Life Sciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACHV shares currently have a short interest ratio of 8.0. Learn More on Achieve Life Sciences's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Achieve Life Sciences: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Achieve Life Sciences saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 717,500 shares, an increase of 2.2% from the previous total of 701,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Achieve Life Sciences: Alpha Teknova, Inc. (0.45%), ARCA biopharma, Inc. (1.37%), Aspira Women's Health Inc. (2.14%), ImmuCell Co. (0.11%), American Well Co. (2.13%), P3 Health Partners Inc. (4.48%), ClearPoint Neuro, Inc. (4.73%), Syros Pharmaceuticals, Inc. (9.89%), Spyre Therapeutics, Inc. (9.36%), CervoMed Inc. (0.60%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling ACHV is an investing strategy that aims to generate trading profit from Achieve Life Sciences as its price is falling. ACHV shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Achieve Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACHV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACHV, twice per month. The most recent reporting period available is March, 31 2024.